Related references
Note: Only part of the references are listed.Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway
Jiting Yan et al.
PHARMACOLOGICAL RESEARCH (2018)
Pathology of non-alcoholic fatty liver disease
Pierre Bedossa
LIVER INTERNATIONAL (2017)
The epidemiology of non-alcoholic fatty liver disease
Stefano Bellentani
LIVER INTERNATIONAL (2017)
Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells
Dong Eon Kim et al.
TOXICOLOGY (2017)
Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system
A. Dash et al.
TOXICOLOGY IN VITRO (2017)
Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis
Maria Ryaboshapkina et al.
SCIENTIFIC REPORTS (2017)
PLIN2 is a Key Regulator of the Unfolded Protein Response and Endoplasmic Reticulum Stress Resolution in Pancreatic β Cells
Elaine Chen et al.
SCIENTIFIC REPORTS (2017)
Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal invitro cell models
Yuanyuan Zhang et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis
A. Roda et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
Swetha Rudraiah et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis
Oksana Sirenko et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2
Seok-Jin Kang et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
Cell sources for in vitro human liver cell culture models
Katrin Zeilinger et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice
Tsunehiro Ochi et al.
HEPATOLOGY RESEARCH (2016)
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid
Noortje Ijssennagger et al.
JOURNAL OF HEPATOLOGY (2016)
Pluripotent stem cells in disease modelling and drug discovery
Yishai Avior et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen
Arnaud Carpentier et al.
STEM CELL RESEARCH (2016)
Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha
Nina Graffmann et al.
STEM CELLS AND DEVELOPMENT (2016)
Novel bile acid therapeutics for the treatment of chronic liver diseases
Vinod S. Hegade et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
Christopher L. Bowlus
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2016)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Ryan E. Feaver et al.
JCI INSIGHT (2016)
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Ok-Kyung Kim et al.
ANNALS OF NUTRITION AND METABOLISM (2015)
Fatty Acid Trafficking in Starved Cells: Regulation by Lipid Droplet Lipolysis, Autophagy, and Mitochondrial Fusion Dynamics
Angelika S. Rambold et al.
DEVELOPMENTAL CELL (2015)
Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway
Claudia Filozof et al.
DRUGS (2015)
Enhancing the Functional Maturity of Induced Pluripotent Stem Cell-Derived Human Hepatocytes by Controlled Presentation of Cell-Cell Interactions In Vitro
Dustin R. Berger et al.
HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Pharmacotherapy for Nonalcoholic Fatty Liver Disease
Samer Gawrieh et al.
SEMINARS IN LIVER DISEASE (2015)
Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing
Jingtao Lu et al.
TOXICOLOGICAL SCIENCES (2015)
Human induced pluripotent stem cell-derived hepatocytes for toxicology testing
David A. Mann
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Non-alcoholic fatty liver disease in 2015
Monjur Ahmed
WORLD JOURNAL OF HEPATOLOGY (2015)
Recent advances in the development of farnesoid X receptor agonists
Ahmad H. Ali et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell-Derived Cells
Oksana Sirenko et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease
Cynthia A. Moylan et al.
HEPATOLOGY (2014)
Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
Shan Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis
Mina Hamano et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant
Takanori Takebe et al.
NATURE PROTOCOLS (2014)
Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes
Kazuo Takayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease
April D. Lake et al.
TOXICOLOGICAL SCIENCES (2014)
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease
Xue-Qun Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Molecular pathways in non-alcoholic fatty liver disease
Alba Berlanga et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies
J. Fraczek et al.
ARCHIVES OF TOXICOLOGY (2013)
Detection and quantification of endoplasmic reticulum stress in living cells using the fluorescent compound, Thioflavin T
Daniel R. Beriault et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
Human iPSC-Derived Hepatocytes
David A. Mann et al.
Genetic Engineering & Biotechnology News (2013)
Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor
Hyunsun Jo et al.
HEPATOLOGY (2013)
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Elena Maneschi et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells
Dian-liang Fang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Production of hepatocyte-like cells from human pluripotent stem cells
Nicholas R. F. Hannan et al.
NATURE PROTOCOLS (2013)
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Yongjie Ma et al.
PHARMACEUTICAL RESEARCH (2013)
Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
Alexandra K. Leamy et al.
PROGRESS IN LIPID RESEARCH (2013)
The Unfolded Protein Response in Fatty Liver Disease
Anne Henkel et al.
SEMINARS IN LIVER DISEASE (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Single-step protocol for the differentiation of human-induced pluripotent stem cells into hepatic progenitor-like cells
Minoru Tomizawa et al.
BIOMEDICAL REPORTS (2013)
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
Seung-Hoi Koo
CLINICAL AND MOLECULAR HEPATOLOGY (2013)
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
H. H. J. Gerets et al.
CELL BIOLOGY AND TOXICOLOGY (2012)
Lipid-Induced Endoplasmic Reticulum Stress in Liver Cells Results in Two Distinct Outcomes: Adaptation with Enhanced Insulin Signaling or Insulin Resistance
Caroline S. Achard et al.
ENDOCRINOLOGY (2012)
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol
Yu-Fan Chen et al.
HEPATOLOGY (2012)
Lipotoxicity in NASH
Michael Fuchs et al.
JOURNAL OF HEPATOLOGY (2012)
Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model
Jin-Sook Lee et al.
TOXICOLOGY LETTERS (2012)
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
Verena Keitel et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Endoplasmic Reticulum Stress and the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Christopher L. Gentile et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Fibroblast Growth Factor 19 Treatment Ameliorates Disruption of Hepatic Lipid Metabolism in Farnesoid X Receptor (Fxr)-Null Mice
Masaaki Miyata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
Xuesong Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Constitutive Role for IRE1α-XBP1 Signaling Pathway in the Insulin-Mediated Hepatic Lipogenic Program
Jie Ning et al.
ENDOCRINOLOGY (2011)
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Maria Eugenia Miquilena-Colina et al.
GUT (2011)
Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
Anastassia Amaro et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice
Jae-Seong Yang et al.
PLOS ONE (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss
Margaret F. Gregor et al.
DIABETES (2009)
Bile Acids Activate Fibroblast Growth Factor 19 Signaling in Human Hepatocytes to Inhibit Cholesterol 7 alpha-Hydroxylase Gene Expression
Kwang-Hoon Song et al.
HEPATOLOGY (2009)
GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice
Helene L. Kammoun et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells
Yuren Wei et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Live-Cell Imaging of Caspase Activation for High-Content Screening
Christophe Antczak et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
Tsuguhito Ota et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
Cheol Soo Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes
Andrea De Gottardi et al.
LABORATORY INVESTIGATION (2007)
A human hepatocellular in vitro model to investigate steatosis
Maria Jose Gomez-Lechon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Steatosis as a risk factor in liver surgery
Reeta Vetelainen et al.
ANNALS OF SURGERY (2007)
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes
Umut Oezcan et al.
SCIENCE (2006)
Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells
Yuren Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
KL Donnelly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties
D Ito et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease
J Araya et al.
CLINICAL SCIENCE (2004)
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
U Özcan et al.
SCIENCE (2004)
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
M Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury
MJ Walsh et al.
HEPATOLOGY (2004)
Structural basis for bile acid binding and activation of the nuclear receptor FXR
LZ Mi et al.
MOLECULAR CELL (2003)
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
LL Listenberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
